 JACKSON CENTER, PA ACCESSWIRE August 25, 2021 Halberd Corporation OTC PINK:HALB received notification from the Ference Law Firm in Pittsburgh of a Notice of Allowance, by the US Patent Office, for the treatment of Cockayne Syndrome. Cockayne Syndrome is a fatal autosomal recessive neurodegenerative disorder which causes premature aging and severely impaired development of the nervous system. 